Pharmacologic Adjuvants to Reduce Erythropoietin Therapy Dose in Anemia of Chronic Kidney Disease and End Stage Renal Disease
None
Saved in:
| Main Authors: | Siddiqui, Adeel, Siddiqui, Aqeel, Benz, Robert |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2012
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/32310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE ROLE OF ERYTHROPOIETIN IN TREATMENT OF ANEMIA IN CANCER PATIENTS
by: P. G. Berezin, et al.
Published: (2017-06-01) -
Erythropoietin for the treatment of anemia in patients with hematologic disorders
by: R. A. Podgurskaya, et al.
Published: (2022-11-01) -
Recombinant erythropoietin in the treatment of anemia in cancer patients
by: S. V. Vorobiova, et al.
Published: (2022-11-01) -
Treatment of ischemic heart disease in end-stage kidney disease patients on renal replacement therapy
by: Yu. V. Semenova, et al.
Published: (2024-04-01) -
Cardiovascular Disease in End Stage Renal Disease Patients
by: Haragsim, Lukas, et al.
Published: (2011)


